Amanda Marinoff

Amanda Marinoff is a physician-scientist affiliated with the University of California San Francisco (UCSF) and the Helen Diller Family Comprehensive Cancer Center. Her research focuses on identifying biomarkers to improve cancer prognoses and advancing precision medicine approaches for pediatric, adolescent, and young adult patients, particularly in sarcomas and hematologic malignancies.

• Education: Dartmouth College (BA in Neuroscience, 2012), Harvard Medical School (MD, 2017), Residency in Pediatrics (2020), Fellowship in Pediatric Hematology/Oncology (2023), and Advanced Training in Clinical Research Certificate (2023).

Her work bridges lab and clinical settings, emphasizing the development of risk prediction tools, treatment strategies, and clinical trials to reduce side effects and enhance outcomes. Recent publications highlight her contributions to thrombocytopenia management, osteosarcoma genomics, and tyrosine kinase inhibitor (TKI) therapy post-hematopoietic stem cell transplantation (HSCT).

Scientific Awards:

• K12 Scholar, Helen Diller Family Comprehensive Cancer Center (2024-present)
• Outsmarting Osteosarcoma Young Investigator Research Award (2023-2024)
• Campini Foundation Award (2023-present)
• FDA-AACR Oncology Educational Fellow (2023-present)
• Alex’s Lemonade Stand Foundation Center of Excellence Scholar (2021-2023)
• Chan Zuckerberg Biohub Physician-Scientist Fellow (2021-2023)
• NIH T32 scholar (2015)
• Alexandra J. Miliotis Fellowship in Pediatric Oncology, Harvard Medical School (2007)
• Siemens Competition first-place team winner

Dr. Marinoff collaborates with multidisciplinary teams to translate biomarker research into clinical practice, prioritizing pediatric oncology and hematologic malignancies.